News about "Abbott "

Abbott Secures FDA Clearance and CE Nod for Amplatzer Piccolo Heart Device

Abbott has received US FDA clearance and CE Mark for its Amplatzer Piccolo Delivery System, the first device specifically designed to treat premature infants with Patent Ductus Arteriosus (PDA). The system enables precise placement of the Amplatzer Piccolo Occluder in infants, addressing a condition that affects around 20 percent of premature infants.

Abbott | 19/12/2025 | By News Bureau

Abbott Issues Medical Device Correction for FreeStyle Libre 3 Sensors

Abbott has initiated a medical device correction in the United States for specific batches of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose sensors after internal testing found that some units may deliver inaccurate low glucose readings.

Abbott | 26/11/2025 | By Darshana |  193

Abbott to Acquire Exact Sciences in USD 21 Billion Deal, Entering Cancer Diagnostics Sectors

After the transaction, Exact Sciences—projected to generate more than USD 3 billion in revenue this year with high-teens organic growth—will operate as a subsidiary of Abbott.

Abbott | 21/11/2025 | By Dineshwori

Abbott Launches World?s First Dual-Chamber Leadless Pacemaker System in India

Abbott launches the world’s first AVEIR dual-chamber leadless pacemaker in India, enabling proper heart rhythm without wires or surgical pockets.

Abbott | 06/10/2025 | By Dineshwori

Abbott Introduces FreeStyle Libre 2 Plus: Continuous Glucose Monitoring Without Fingersticks

Abbott, a global healthcare leader, has launched the FreeStyle Libre 2 Plus sensor in India, a device that delivers automatic glucose readings every minute directly to a user’s smartphone. The innovation aims to provide people living with diabetes greater confidence, precision, and ease in managing their condition.

Abbott | 22/08/2025 | By Darshana |  243

Abbott Introduces Lab-Based Blood Test to Help Evaluate Mild Traumatic Brain Injury

The diagnostic tool also helps eliminate the need for CT scans by up to 40 percent with a high degree of certainty eliminating wait time at the hospital and unnecessary exposure to radiation.

Abbott | 25/06/2025 | By Darshana |  192

Abbott Secures CE Mark for its Volt Pulsed Field Ablation System to Treat Patients with AFib

With the earlier-than-expected CE Mark, Abbott has begun commercial PFA cases in the EU with physicians who have already gained experience with the Volt PFA System within Abbott's PFA clinical studies.

Abbott | 31/03/2025 | By Aishwarya |  338

Abbott Inaugurates New Global Manufacturing Facility in Ireland

The Kilkenny facility is part of a EUR 440 million investment in Ireland, which includes a significant expansion of the company’s Donegal site, where a further 200 jobs are being created.

Abbott | 19/11/2024 | By Aishwarya |  606

Abbott Launches New Technology to Support Advanced Cardiac Mapping

Abbott's investigational Volt PFA System was designed to overcome prior limitations in PFA systems by pairing a balloon-in-basket catheter with Abbott's EnSits X EP System, an heart mapping solution.

Abbott | 11/10/2024 | By Aishwarya |  446

Abbott Announces Availability of Lingo Continuous Glucose Monitor in US

Lingo is based on Abbott's world-leading FreeStyle Libre continuous glucose monitoring technology, now used by more than 6 million people with diabetes globally.

Abbott | 06/09/2024 | By Aishwarya |  580